Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

High-Intensity Interval Training, Inflammatory Biomarkers, and Circulating MicroRNAs in Human Clinical Obesity.

16. november 2026 opdateret af: Sofia Uribe-Cerda, Universidad Nacional Andres Bello

Effects of High-Intensity Interval Training on Body Composition, Inflammatory Biomarkers, and Circulating MyomiRs in Adults With Clinical Obesity: A Randomized Controlled Trial.

This randomized controlled trial evaluates the effects of high-intensity interval training (HIIT) on body composition, inflammatory biomarkers, and circulating microRNAs in adults with clinical obesity. Circulating microRNAs are small regulatory molecules that may reflect exercise-induced adaptations and inter-tissue communication related to skeletal muscle and metabolic health. The study investigates whether exercise-induced changes in adiposity are accompanied by changes in inflammatory status and circulating microRNA profiles associated with skeletal muscle adaptations and metabolic health.

Studieoversigt

Status

Ikke rekrutterer endnu

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Clinical obesity is characterized by excessive adiposity accompanied by impaired metabolic health and chronic low-grade inflammation. Emerging evidence suggests that obesity is also associated with alterations in circulating molecular biomarkers that may influence skeletal muscle function and inter-tissue communication.

High-intensity interval training (HIIT) is an effective exercise strategy for improving body composition and cardiometabolic health; however, the molecular mechanisms underlying these adaptations remain incompletely understood. In particular, limited information is available regarding the response of circulating muscle-related microRNAs (myomiRs) to exercise interventions in adults with clinical obesity.

This randomized controlled trial is designed to investigate physiological and molecular adaptations to HIIT in adults with clinical obesity. The study will examine the relationship between changes in adiposity, systemic inflammation, and circulating microRNA expression following a supervised exercise intervention. Circulating microRNAs may provide insight into exercise-responsive biological pathways and represent potential biomarkers of skeletal muscle adaptation and metabolic health.

The findings may improve understanding of the molecular mechanisms associated with exercise-induced health benefits in clinical obesity and contribute to the identification of novel biomarkers relevant to obesity management and precision exercise medicine.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

17

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

    • Metropolitan Region
      • Santiago, Metropolitan Region, Chile
        • Exercise and Rehabilitation Sciences Institute, School of Physical Therapy, Faculty of Rehabilitation Sciences, Universidad Andres Bello.

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

20 år til 39 år (Voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Adults aged 20 to 39 years.
  • Clinical obesity defined primarily by body fat percentage (>29% in women and >20% in men), complemented by body mass index (BMI ≥30 kg/m²) and waist-to-height ratio (≥0.55).
  • Low habitual physical activity level, defined as not meeting the criteria for moderate or high physical activity according to the International Physical Activity Questionnaire-Short Form (IPAQ-SF).

Exclusion Criteria:

  • Cardiovascular disease.
  • Metabolic disease (e.g., type 2 diabetes mellitus or dyslipidemia).
  • Inflammatory or autoimmune disease (e.g., rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, or psoriasis).
  • Current smoking.
  • Chronic medication use that may affect metabolic or inflammatory outcomes.
  • Pregnancy and lactation.
  • Participation in a structured exercise program within the previous 6 months. Contraindications to high-intensity exercise.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Grundvidenskab
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: High-Intensity Interval Training (HIIT)

Participants assigned to this arm will complete a supervised high-intensity interval training (HIIT) program performed on a cycle ergometer three times per week during 8 weeks. Each training session will last approximately 30 minutes and include a warm-up, high-intensity intervals performed at approximately 90% of maximal power output, active recovery periods, and a cool-down. All sessions will be supervised by qualified personnel to ensure participant safety and adherence to the protocol.

Participants will complete a supervised high-intensity interval training (HIIT) program performed on a cycle ergometer three times per week during eight weeks. Each session will last approximately 30 minutes and consist of a warm-up, ten 1-minute high-intensity intervals performed at approximately 90% of maximal power output, interspersed with 1-minute active recovery periods, and a cool-down. Training intensity will be reassessed midway through the intervention to ensure appropriate progression. All sessions will be supervised by qualified personnel to promote adherence, proper exercise execution, and participant safety.

Ingen indgriben: Control

Participants assigned to this arm will maintain their habitual lifestyle without participating in a structured exercise program during the intervention period. Educational materials on healthy lifestyle habits will be provided at the end of the study.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Total Body Fat Mass Assessed by Bioelectrical Impedance Analysis
Tidsramme: Change from baseline to Week 8

Total body fat mass (kg) will be assessed using bioelectrical impedance analysis and compared between baseline and post-intervention measurements.

Change from baseline to Week 8

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Plasma Interleukin-1β (IL-1β) and Tumor Necrosis Factor-α (TNF-α) concentration Assessed by ELISA
Tidsramme: From baseline to Week 8

Plasma IL-1β concentration (pg/mL) and TNF-α concentration (pg/mL) measured by enzyme-linked immunosorbent assay (ELISA).

From baseline to Week 8
Circulating Myo-MicroRNAs
Tidsramme: from enrollment to the end of treatment at 8 weeks

Change in circulating expression of miR-1, miR-133, and miR-206 quantified by RT-qPCR.

from enrollment to the end of treatment at 8 weeks
Peak Oxygen Uptake (VO₂peak)
Tidsramme: From baseline to Week 8

Change in cardiorespiratory fitness assessed by peak oxygen uptake during an incremental cycling test.

From baseline to Week 8
Handgrip Strength
Tidsramme: From baseline to Week 8

Change in maximal handgrip strength assessed using a hydraulic hand dynamometer.

From baseline to Week 8
Maximal Voluntary Isometric Contraction (MVC)
Tidsramme: From baseline to Week 8

Change in maximal isometric strength of the knee extensor muscles measured by dynamometry.

From baseline to Week 8
Health-Related Quality of Life Assessed Using the 36-Item Short Form Health Survey (SF-36)
Tidsramme: From baseline to Week 8

Change in health-related quality of life assessed using the 36-Item Short Form Health Survey (SF-36). Scores range from 0 to 100, with higher scores indicating better perceived health status and quality of life.

From baseline to Week 8

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. november 2026

Primær færdiggørelse (Anslået)

1. juni 2027

Studieafslutning (Anslået)

1. oktober 2027

Datoer for studieregistrering

Først indsendt

29. oktober 2026

Først indsendt, der opfyldte QC-kriterier

16. november 2026

Først opslået (Faktiske)

18. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

18. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

16. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 64B2025

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .